secwatch.observer — SEC 8-K summary
======================================

Issuer:     Prime Medicine, Inc. (PRME)
CIK:        0001894562
Form:       8-K
Filed at:   2024-01-05T23:59:59+00:00
Accession:  0001628280-24-000676
Event type: litigation
Sentiment:  negative
Materiality: 0.55
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Prime Medicine settles arbitration with Myeloid for $13.5M payment
------------------------------------------------------------------

- Company to pay Myeloid $13.5M to resolve two arbitration proceedings related to former research collaboration.
- Settlement includes mutual covenants and release of all claims between parties.
- Arbitrations previously disclosed in Q3 2023 Form 10-Q.
- Agreement dated January 4, 2024, entered into between Prime Medicine and Myeloid.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1894562/000162828024000676/0001628280-24-000676-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1894562/000162828024000676/prme-20240104.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-000676

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer